Takeshi Tokoroyama1, Minoru Ando1,2, Kyogo Setoguchi3, Ken Tsuchiya1, Kosaku Nitta1. 1. Department IV of Internal Medicine, Tokyo Women's Medical University, Tokyo, Japan. 2. Department of Medicine, Tokyo Metropolitan Fu-chu Medical and Welfare Center, 2-9-2, Musashidai, Fu-chu City, Tokyo 183-8553, Japan. 3. Division of Collagen Disease, Department of Medicine, Tokyo Metropolitan Komagome Hospital, Bunkyo, Tokyo 113-0021, Japan.
Abstract
BACKGROUND: The prevalence, incidence and prognosis of chronic kidney disease (CKD) have not been fully understood in rheumatoid arthritis (RA) patients. METHODS: A retrospective cohort study was performed in 1077 RA patients from July 2004 to June 2014. CKD was defined as either proteinuria ≥1+ or estimated glomerular filtration rate (eGFR) <60 mL/min/1.73 m2 or both, according to the current CKD classification with risk categories for future death, end-stage renal disease and cardiovascular disease. The cumulative incidence of mortality and CKD was analyzed using the Kaplan-Meier method. The association of each outcome with known risk factors was analyzed using multivariate Cox proportional hazards regression models. Hazard ratios (HRs) with 95% confidence intervals (CIs) for mortality and incidence of CKD were calculated for estimation. RESULTS: The mean follow-up period was 51.5 ± 39.6 months, and the cumulative mortality was 20.6% over 10 years. The prevalence of any CKD was 24.5% at enrollment. Preexisting CKD was significantly associated with future death [HR 1.64 (95% CI 1.05-2.57)]. This association was the most robust in very-high-risk CKD [HR 4.76 (95% CI 2.24-9.51)]. The cumulative incidence of CKD over time was 59.5% in 813 patients who did not have prior CKD. Aside from the commonly known risk factors, the use of prednisolone and nonsteroidal anti-inflammatory drugs increased the likelihood of death [HR 1.75 (95% CI 1.11-2.79)] and incident CKD [HR 1.44 (95% CI 1.13-1.86)]. CONCLUSIONS: The incidence of CKD increases over time among RA patients and prevalent CKD may be an insidious risk factor linked to increased mortality in RA patients.
BACKGROUND: The prevalence, incidence and prognosis of chronic kidney disease (CKD) have not been fully understood in rheumatoid arthritis (RA) patients. METHODS: A retrospective cohort study was performed in 1077 RA patients from July 2004 to June 2014. CKD was defined as either proteinuria ≥1+ or estimated glomerular filtration rate (eGFR) <60 mL/min/1.73 m2 or both, according to the current CKD classification with risk categories for future death, end-stage renal disease and cardiovascular disease. The cumulative incidence of mortality and CKD was analyzed using the Kaplan-Meier method. The association of each outcome with known risk factors was analyzed using multivariate Cox proportional hazards regression models. Hazard ratios (HRs) with 95% confidence intervals (CIs) for mortality and incidence of CKD were calculated for estimation. RESULTS: The mean follow-up period was 51.5 ± 39.6 months, and the cumulative mortality was 20.6% over 10 years. The prevalence of any CKD was 24.5% at enrollment. Preexisting CKD was significantly associated with future death [HR 1.64 (95% CI 1.05-2.57)]. This association was the most robust in very-high-risk CKD [HR 4.76 (95% CI 2.24-9.51)]. The cumulative incidence of CKD over time was 59.5% in 813 patients who did not have prior CKD. Aside from the commonly known risk factors, the use of prednisolone and nonsteroidal anti-inflammatory drugs increased the likelihood of death [HR 1.75 (95% CI 1.11-2.79)] and incident CKD [HR 1.44 (95% CI 1.13-1.86)]. CONCLUSIONS: The incidence of CKD increases over time among RA patients and prevalent CKD may be an insidious risk factor linked to increased mortality in RA patients.
Authors: Badreldin H Ali; Turan Karaca; Yousuf Al Suleimani; Mohammed Al Za'abi; Jamila Al Kalbani; Mohammed Ashique; Abderrahim Nemmar Journal: PLoS One Date: 2017-04-26 Impact factor: 3.240
Authors: Milton Packer; Carolyn S P Lam; Lars H Lund; Mathew S Maurer; Barry A Borlaug Journal: Eur J Heart Fail Date: 2020-06-26 Impact factor: 15.534
Authors: Jie Tang; Binwu Ying; Yuwei Yang; Bei Xu; Lin Yu; Wenqiang Jiang; Shutao Pu Journal: Oxid Med Cell Longev Date: 2022-04-22 Impact factor: 7.310